Immune down-regulation and peripheral deletion of CD8 T cells does not require TNF receptor-ligand interactions nor CD95 (Fas, APO-1)

European Journal of Immunology

Volumn 30, Issue 2, 2000, Pages 678-682

  Reich, Arno ^a   Körner, Heinrich ^b   Sedgwick, Jonathon D ^c   Pircher, Hanspeter ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Apoptosis; CD8 T cell; CD95; TCR transgenic mice; TNF

Indexed keywords

CD8 ANTIGEN; EPITOPE; FAS ANTIGEN; LIGAND; PEPTIDE; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL KINETICS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MALE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SPLEEN CELL; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD95; APOPTOSIS; CD8-POSITIVE T-LYMPHOCYTES; DOWN-REGULATION; MICE; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION;

EID: 0342470585     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200002)30:2<678::AID-IMMU678>3.0.CO;2-Q     Document Type: Article

References (23)

1. Lenardo, M., Chan, K. M., Hornung, F., McFarland, H., Siegel, R., Wang, J. and Zheng, L., Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 1999. 17: 221-253.
2. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A. and Nagata, S., Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992. 356: 314-317.
3. Scott, D. E., Kisch, W. J. and Steinberg, A. D., Studies of T cell deletion and T cell anergy following in vivo administration of SEB to normal and lupus-prone mice. J. Immunol. 1993. 150: 664-672.
4. Singer, G. G. and Abbas, A. K., The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1994. 1: 365-371.
5. Sytwu, H.-K., Liblau, R. S. and McDevitt, H. O., The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 1996. 5: 17-30.
6. Russell, J. H., Rush, B., Weaver, C. and Wang, R., Mature T cells of autoimmune Ipr/Ipr mice have a defect in antigen-stimulated suicide. Proc. Natl. Acad. Sci. USA 1993. 90: 4409-4413.
7. Dhein, J., Walczak, H., Bäumler, C., Debatin, K.-M. and Krammer, P. H., Autocrine T-cell suicide mediated by Apo-1/Fas/ CD95. Nature 1995. 373: 438-385.
8. Brunner, T., Mogil, R. J., LaFace, D., Yoo, N. J., Mahboubi, A., Echeverri, F., Martin, S. J., Force, W. R., Lynch, D. H. and Ware, C. F., Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995. 373: 441-444.
9. Ju, S. T., Panka, D. J., Cui, H., Ettinger, R., el Khatib, M., Sherr, D. H., Stanger, B. Z. and Marshak Rothstein, A., Fas(CD95)/ FasL interactions required for programmed cell death after T-cell activation. Nature 1995. 373: 444-448.
10. Ehl, S., Hoffmann-Rohrer, U., Nagata, S., Hengartner, H. and Zinkernagel, R., Different susceptibility of cytotoxic T cells to CD95 (Fas/Apo-1) ligand-mediated cell death after activation in vitro versus in vivo. J. Immunol. 1996. 156: 2357-2360.
11. Lohman, B. L., Razvi, E. S. and Welsh, R. M., T-lymphocyte downregulation after acute viral infection is not dependent on CD95 (Fas) receptor-ligand interactions. J. Virol. 1996. 70: 8199-8203.
12. + T cells after antigen challenge in the absence of Fas (CD95). Eur. J. Immunol. 1996. 26: 2903-2910.
13. + T cells creates double-negative cells in vivo. J. Immunol. 1998. 161: 1686-1693.
14. Zheng, L., Fisher, G., Miller, R. E., Peschon, J., Lynch, D. H. and Lenardo, M. J., Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 1995. 377: 348-351.
15. Alexander-Miller, M. A., Leggatt, G. R., Sarin, A. and Berzofsky, J. A., Role of antigen, CDS, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL. J. Exp. Med. 1996. 184: 485-492.
16. Speiser, D. E., Sebzda, E., Bachmann, M. F., Pfeffer, K., Tak, M. and Ohashi, P. S., Tumor necrosis receptor 55 mediates deletion of peripheral cytotoxic T lymphocytes in vivo. Eur. J. Immunol. 1996. 26: 3055-3060.
17. Page, D. M., Roberts, E. M., Peschon, J. J. and Hedrik, S. M., TNF receptor-deficient mice reveal striking differences between several models of thymocyte negative selection. J. Immunol. 1998. 160: 120-133.
18. Zhou, T., Edwards, C. K., Yang, P., Wang, Z., Bluethmann, H. and Mountz, J. d., Greatly accelerated lymphadenopathy and autoimmune disease in Ipr mice lacking tumor necrosis factor receptor I. J. Immunol. 1996. 156: 2661-2665.
19. Sidman, C. L., Marshall, J. D. and von Boehmer, H., Transgenic T cell receptor interactions in the lymphoproliferative and autoimmune syndromes of Ipr and gld mutant mice. Eur. J. Immunol. 1992. 22: 499-504.
20. + T cells in Ipr/Ipr mice. J. Exp. Med. 1990. 172: 1805-1817.
21. + T cells to cause immunopathology. J. Exp. Med. 1998. 187: 763-774.
22. Pfeffer, K., Matsuyama, T., Kündig, T. M., Wakeham, A., Kishihara, K., Shahinian, A., Wiegmann, K., Ohashi, P. S., Krönke, M. and Mak, T. W., Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L.monocytogenes infection. Cell 1993. 73: 457-467.
23. Körner, H., Cook, M., Riminton, D. S., Lemckert, F. A., Hoek, R. M., Ledermann, B., Köntgen, R., Fazekas de St. Groth, B. and Sedgwick, J. D., Distinct roles for lymphotoxin-α and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur. J. Immunol. 1997. 27: 2600-2609.